SK Bioscience announced on the 27th that the company’s CEO, Jae-Yong Ahn, participated in the ‘2023 Riyadh Global Medical Biotechnology Summit’ that was held in Riyadh, the capital of the Kingdom of Saudi Arabia, and proposed a partnership for vaccine supply on the 25th (local time).

The Riyadh Summit, which celebrated its second event this year, is a national bio event where major bio-industry officials from the US and Europe gather to share future R&D prospects and investment strategies for the bio industry. At the event, CEO Ahn gave a session presentation on the theme, 'Preparing for Next Pandemic through Global Partnership'.

During presentations, CEO Ahn shared his compa